Clinical Trials · NCT06282458
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Veru Inc.
- Enrollment
- 168
- Start date
- Apr 2024
- Locations
- 14 sites, United States
- Primary endpoint
- The primary endpoint for the study is the percentage change from baseline in total lean body mass at 112 days.